Recent News

• 09.17.2025 - X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
• 09.17.2025 - X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
• 08.15.2025 - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.15.2025 - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 09.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.10.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 09.10.2025 - S-3 Registration statement under Securities Act of 1933
• 08.25.2025 - D Notice of Exempt Offering of Securities
• 08.25.2025 - 8-K Current report
• 08.20.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.19.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.18.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 08.18.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.15.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership